Trial Profile
A Phase I, Double-Blind, Placebo-Controlled Study Assessing Safety, Tolerability and Pharmacokinetics (PK) after High Single and Multiple Doses of Fevipiprant in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Nov 2017
Price :
$35
*
At a glance
- Drugs Fevipiprant (Primary)
- Indications Allergic asthma; Asthma; Atopic dermatitis
- Focus Adverse reactions; Pharmacokinetics
- 17 Nov 2017 New trial record